Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 9/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CCR3 | P51677 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19358917 | 0.89 | SMN1; SMN2 (0.78) | FAAHMEN1KMT2ASMN1; SMN2CCR3 | |
| SCHEMBL3598122 | 0.86 | FAAH (1.00) | FAAHMEN1KMT2ASMN1; SMN2TDP1 | |
| SCHEMBL27004157 | 0.84 | FAAH (0.85) | FAAHMEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL830207 | 0.84 | FAAH (0.74) | FAAHMEN1KMT2ASMN1; SMN2CCR3 | |
| SCHEMBL27004161 | 0.81 | FAAH (0.83) | FAAHMEN1KMT2ASMN1; SMN2TDP1 | |
| SCHEMBL3639088 | 0.79 | FAAH (0.60) | FAAHMEN1KMT2ASMN1; SMN2CCR3 | |
| SCHEMBL3637699 | 0.79 | FAAH (0.59) | FAAHMEN1KMT2ASMN1; SMN2CCR3 | |
| SCHEMBL13902972 | 0.79 | FAAH (0.54) | FAAHMEN1KMT2ASMN1; SMN2CCR3 | |
| SCHEMBL1581690 | 0.78 | ACHE (0.56) | FAAHMEN1KMT2A | |
| SCHEMBL29453749 | 0.78 | ACHE (0.56) | FAAHMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873288-B2 | Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873288-B2 | Inhibitors for soluble epoxide hydrolase (sEH) and fatty acid amide hydrolase (FAAH) | FAAH, FAAH2, EPHX2 | FAAH 1/4885MEN1 4059/4885KMT2A 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.